Perioperative Anaphylaxis to a Neuromuscular Blocker in a Patient with Prior 'Unexplained' Reactions
A 44-year-old woman is scheduled for elective laparoscopic cholecystectomy under general anesthesia. She reports two prior operations: a tonsillectomy at age 9 with facial swelling on emergence, and a cesarean delivery at age 31 with hypotension and diffuse urticaria 10 minutes after induction. Neither episode was investigated. She carries no allergy diagnosis and takes no medications. Preoperative tryptase is 4.1 ng/mL. The anesthesiologist plans propofol, rocuronium, fentanyl, and cefazolin. The patient asks whether she should be 'tested for anesthesia' before surgery, and whether she can just receive 'the safe one' instead. The case is scheduled in 3 weeks and the surgeon is reluctant to delay.
1. Is there enough evidence to justify preoperative allergy workup, and if so, what should be tested and why?
Read the worked answer
Yes - the history is a strong signal. Two temporally plausible perioperative reactions (one mucocutaneous, one with hypotension plus urticaria shortly after induction) constitute a reasonable indication for allergy evaluation. The key reasoning is mechanistic: reactions occurring within minutes of induction point to agents given at induction - neuromuscular blocking agents (NMBAs), induction hypnotics, opioids, and antibiotics. NMBAs are the leading cause of perioperative anaphylaxis in many registries, and cross-reactivity among NMBAs (especially the quaternary ammonium epitope shared by rocuronium, vecuronium, pancuronium, and to a lesser extent others) means 'just give a different one' is not automatically safe.
Workup should include skin prick and intradermal testing for the NMBAs plausibly used, plus the other induction agents and cefazolin, and ideally a latex assessment. Testing must be done at least 4-6 weeks after the index reaction (a false-negative window exists early after anaphylaxis) and by someone experienced in drug allergy, with epinephrine and resuscitation immediately available because testing itself can trigger anaphylaxis. Serum tryptase is not diagnostic here - a normal baseline tryptase does not exclude an IgE-mediated reaction; an acute tryptase drawn 1-2 hours after a reaction is the useful sample.
2. The surgeon pressures the team to proceed in 3 weeks without testing, arguing 'she's had anesthesia twice and survived.' How should you respond, and what is the safest perioperative plan if surgery cannot wait?
Read the worked answer
The 'she survived twice' argument is the exact reasoning that gets patients hurt: severity of prior reactions does not predict severity of the next one, and repeat exposures to an IgE-sensitized drug can produce a more severe reaction. However, the plan is not automatically 'cancel' - it is 'risk-stratify and engineer the exposure.'
If surgery must proceed before complete testing: (1) avoid all NMBAs entirely and use an anesthetic technique that does not require them (e.g., a supraglottic airway or careful intubation with an alternative relaxant only if a tested-safe agent is available - otherwise no relaxant); (2) avoid cefazolin if it is among the untested suspects and substitute an appropriate alternative after discussion; (3) minimize the number of new drugs given, and document each agent and time; (4) premedicate per institutional protocol but recognize premedication does not reliably prevent IgE-mediated anaphylaxis; (5) ensure epinephrine, airway equipment, and a team briefed on the prior reactions are immediately available; (6) draw an acute tryptase if any reaction occurs and refer for testing afterward.
The correct answer is not 'test or cancel' as a binary - it is to remove the highest-risk agents (NMBAs) from the plan, keep the drug list minimal and documented, and complete testing afterward. Delaying 3 weeks to complete skin testing is preferable if clinically feasible, but the safety plan above is the fallback.